Rare Disease Therapeutics: Accelerating Development and Improving Access

Access Resources

Thank you for your interest in our resources. Please fill out the information here to have full access to our library of useful information, including what you are looking for currently.

Name(Required)

Work Email(Required)

Company(Required)

Your Region(Required)

Your Country

U.S. State

European Country

Hidden

Your Country

Hidden

U.S. State

Hidden

Territory

By submitting this data form, you consent to WuXi AppTec collecting and processing the information you provided for our internal use, in accordance with our Privacy Policy.

← Return to Resources

Related Content

Pioneering Advanced Modalities in Early Drug Discovery

New modalities such as peptides, oligonucleotides, and cell and gene therapies have revolutionized healthcare industry innovation. To meet these evolving...

VIEW RESOURCE

PD-1 Blockade Protein in 4th Generation Armored CAR-T Cells Enhances Cytotoxicity Effect with in vitro Re-challenge System

Chimeric antigen receptor (CAR)-T cells are genetically engineered T cells that express a surface receptor to recognize tumor-associated antigens (TAA)....

VIEW RESOURCE

← View all Cell Therapies Resources

×

Access Resources

Related Content

Pioneering Advanced Modalities in Early Drug Discovery

PD-1 Blockade Protein in 4th Generation Armored CAR-T Cells Enhances Cytotoxicity Effect with in vitro Re-challenge System

Contact An Expert Today!